Loading…
Loading…

| JNJJNJJohnson & Johnson | Johnson & Johnson | $266.30 | $641.1B |
| ABBVABBVAbbVie Inc. | AbbVie Inc. | $286.79 | $506.8B |
| MRKMRKMerck & Co., Inc. | Merck & Co., Inc. | $140.61 | $346.9B |
| AZNAZNAstraZeneca PLC | AstraZeneca PLC | $172.06 | $266.8B |
| GILDGILDGilead Sciences, Inc. | Gilead Sciences, Inc. | $158.69 | $196.8B |
| NVONVONovo Nordisk A/S | Novo Nordisk A/S | $39.13 | $173.0B |
| PFEPFEPfizer Inc. | Pfizer Inc. | $29.79 | $169.8B |
| BMYBMYBristol-Myers Squibb Company | Bristol-Myers Squibb Company | $61.61 | $125.9B |
| GSKGSKGSK plc | GSK plc | $51.10 | $102.4B |
| SNYSNYSanofi | Sanofi | $41.79 | $100.2B |